Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-11-20

Clinical Trial Update: Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC)

View source ↗

Summary

This is an observational cohort study update for castration-resistant prostate cancer, including metastatic cases, registered as NCT02380274 and reported as com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Astellas Pharma Global Development, Inc. | Conditions: Prostate Cancer, Castration-resistant Prostate Cancer | Status: COMPLETED